Nobel Prize Inspiration Initiative event on stem cells

Lecture "A new era of medicine with induced pluripotent stem cells – iPS cells" and panel discussion "Implications of Stem Cell Therapy for Patients and Society" with Shinya Yamanaka, 2012 Nobel Laureate in Physiology or Medicine. 

Nobel Laureate Shinya Yamanaka. Illustration with courtesy of Andy Potts.

Read the news article about the importance of Yamanaka's work: In Norwegian or English.

The event is a part of the Nobel Prize Inspiration Initiative (NPII), a global programme that brings Nobel Laureates to universities and research centres, to inspire and engage scientists at all stages of their careers, especially students and young scientists.

The Initiative is organised by Nobel Media, the company managing media rights for the Nobel Prize, in partnership with the global biopharmaceutical company AstraZeneca.

The event in Oslo is hosted by UiO:Life Science ­– the largest interdisciplinary strategic initiative at UiO.

Programme

10.00–11.30 A new era of medicine with induced pluripotent stem cells – iPS Cells

Open lecture with audience Q&A

Shinya Yamanaka, 2012 Nobel Laureate in Physiology or Medicine

Venue: University of Oslo, Blindern, Georg Sverdrups hus, Auditorium 1

12.00­–13:00 Implications of Stem Cell Therapy for Patients and Society

Panel discussion with

  • Shinya Yamanaka, 2012 Nobel Laureate in Physiology or Medicine
  • Morten Carstens Moe, Professor II, Faculty of Medicine, University of Oslo
  • Anna Smajdor, Associate Professor, Faculty of Humanities, University of Oslo
  • Birgit Skarstein, Athlete and member of the Norwegian Biotechnology Advisory Board

Venue: University of Oslo, Blindern, Vilhelm Bjerknes' hus, the Foyer of the Science Library

Register for the events no later than August 31

About Shinya Yamanaka

Shinya Yamanaka, born in Osaka 1962, Nobel Laureate in Physiology or Medicine 2012.

Professor Shinya Yamanaka is most recognised for his discovery of induced pluripotent stem (iPS) cells, which are differentiated cells that have been reprogrammed to the pluripotent state. He is the director of the Center for iPS Cell Research and Application (CiRA), which was founded in 2008 in response to his discovery, at Kyoto University, and a senior investigator at the Gladstone Institutes in the United States.

He was an orthopaedic surgeon, earning his MD in 1987 from Kobe University. After receiving a PhD in 1993 from Osaka City University (OCU), he went to the Gladstone Institutes as a postdoctoral fellow, where he first learned genetics and the use of embryonic stem cells. In 1996, he returned to Japan and has since continuously researched pluripotency. After serving as a faculty member at OCU and Nara Institute of Science and Technology, he has been a professor at Kyoto University since 2004.

The awards and honours he has received include the Albert Lasker Basic Medical Research Award, the Kyoto Prize in Advanced Technology, the Wolf Prize in Medicine, the Imperial Prize, the Japan Academy Prize, the Order of Culture (Japan) and the Nobel Prize in Physiology or Medicine.

Source: Nobel Media

Published May 15, 2017 4:44 PM - Last modified June 26, 2017 4:22 PM